Augmentation Strategies to Improve Treatment of Major Depression

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 6, Iss. 2, 2006-01 ,pp. : 135-152

Bentham Science Publishers

Access to resources Recommend Favorite

A Benefit-Risk Assessment of Agomelatine in the Treatment of Major Depression

By Howland Robert H.  

Drug Safety, Vol. 34, Iss. 9, 2011-09 ,pp. : 709-731

Adis International

Access to resources Recommend Favorite

A review of the efficacy and tolerability of agomelatine in the treatment of major depression

By Ghosh Anita   Hellewell Jonathan SE  

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 12, 2007-12 ,pp. : 1999-2004

Informa Healthcare

Access to resources Recommend Favorite

Brain Structural Effects of Antidepressant Treatment in Major Depression

By  

Current Neuropharmacology, Vol. 13, Iss. 4, 2015-01 ,pp. : 458-465

Bentham Science Publishers

Access to resources Recommend Favorite

Astrocytes and Gliotransmitters: New Players in the Treatment of Major Depression?

By  

Current Drug Targets, Vol. 14, Iss. 11, 2013-10 ,pp. : 1295-1307

Bentham Science Publishers

Access to resources Recommend Favorite